Bruker Corporation (NASDAQ:BRKR) to Issue $0.05 Quarterly Dividend

Bruker Corporation (NASDAQ:BRKR) declared a quarterly dividend on Thursday, May 14th. Investors of record on Monday, June 22nd will be given a dividend of 0.05 per share by the medical research company on Tuesday, July 7th. This represents a c) dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Monday, June 22nd.

Bruker has increased its dividend by an average of 0.0%annually over the last three years. Bruker has a payout ratio of 7.3% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Bruker to earn $2.44 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 8.2%.

Bruker Stock Performance

Shares of BRKR stock opened at $57.23 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.55 and a quick ratio of 0.72. The company has a market cap of $8.71 billion, a price-to-earnings ratio of -238.46, a PEG ratio of 1.83 and a beta of 1.31. The stock has a 50 day simple moving average of $46.54 and a 200-day simple moving average of $44.14. Bruker has a 1-year low of $28.53 and a 1-year high of $64.54.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Wednesday, May 6th. The medical research company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.08. The firm had revenue of $823.40 million for the quarter, compared to analysts’ expectations of $795.62 million. Bruker had a negative net margin of 0.65% and a positive return on equity of 11.60%. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.47 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, equities research analysts expect that Bruker will post 2.12 EPS for the current fiscal year.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.